Bio-Pharmaceutical Logistics Market to Reach $257.81 Billion by 2030, Cold Chain at 69%, DHL as Market Leader

bio_pharmaceutical_logistics_global_market_report_Comp_And_Segment

bio_pharmaceutical_logistics_global_market_report_Regions_And_Drivers

bio_pharmaceutical_logistics_global_market_report

The Business Research Company's Bio-Pharmaceutical Logistics Market Report 2026 – Market Size, Trends, And Global Forecast 2026-2035

LONDON, GREATER LONDON, UNITED KINGDOM, October 8, 2026 /EINPresswire.com/ -- "The bio-pharmaceutical logistics sector is experiencing significant growth as the demand for specialized transportation and storage solutions for sensitive medical products increases. This market plays a vital role in ensuring the safe and effective delivery of biologics, vaccines, and other temperature-sensitive pharmaceuticals. Understanding the current market size, growth drivers, key players, and regional trends offers valuable insight into this rapidly expanding field.

Bio-Pharmaceutical Logistics Market Overview and Size by 2030
The bio-pharmaceutical logistics market is forecasted to exceed $258 billion by 2030. Its broader parent industry, Freight Forwarding, is expected to reach about $277 billion in the same year, with approximately 93% of this attributed to bio-pharmaceutical logistics. Within the extensive Transport Services industry, projected to hit $12,477 billion by 2030, bio-pharmaceutical logistics will make up close to 2% of the total market value. This reflects a robust growth trajectory fueled by rising complexities in pharmaceutical transportation.

Request A Free Sample Of The Bio-Pharmaceutical Logistics Market Report
https://thebusinessresearchcompany.com/sample_request?id=8947&type=smp&name=Bio-Pharmaceutical%20Logistics%20Market%20Report%202026&utm_source=EINPresswire&utm_medium=Paid&utm_campaign=Oct_PR

Key Drivers Propelling the Bio-Pharmaceutical Logistics Market Forward
A major force fueling the market’s expansion is the rising need for temperature-controlled logistics to handle biopharmaceuticals. Products such as biologics, vaccines, cell and gene therapies, and specialty medicines require stringent temperature regulation during transport and storage to maintain their potency and safety. This demand for sophisticated cold chain logistics, including specialized packaging and real-time monitoring, is expected to contribute around 2.8% growth annually to the market.

Another significant driver is the ongoing global expansion in biologics and vaccine distribution. Pharmaceutical companies are increasingly commercializing biosimilars, specialty drugs, and vaccines worldwide, creating greater demand for dependable warehousing, transportation, inventory management, and international shipping services. This trend is projected to add approximately 2.6% annual growth to the bio-pharmaceutical logistics sector.

Access The Detailed Bio-Pharmaceutical Logistics Market Report Here
https://thebusinessresearchcompany.com/report/bio-pharmaceutical-logistics-global-market-report?utm_source=EINPresswire&utm_medium=Paid&utm_campaign=Oct_PR

The adoption of advanced monitoring and tracking technologies also plays a crucial role. Innovations like IoT sensors, GPS tracking, and digital platforms enable real-time visibility of shipments, temperature control, predictive risk management, and compliance with regulations. These technologies help minimize spoilage risks and maintain product integrity, contributing roughly 2.4% growth annually to the market’s overall expansion.

Bio-Pharmaceutical Logistics Market Segments and Leading Category
The market is primarily divided into two segments by service type: cold chain logistics and non-cold chain logistics. Cold chain logistics is poised to be the dominant segment by 2030, representing 69% of the market or about $178 billion. This segment’s growth is driven by the increasing volume of temperature-sensitive cell and gene therapies, which require precise temperature control, continuous monitoring, and specialized insulated packaging to comply with Good Distribution Practice (GDP) standards across global pharmaceutical supply chains.

Further segmentation includes services such as transportation, warehousing and distribution, and value-added offerings. Retail formats cover specialty stores and hypermarkets, while application-wise, the market breaks down into ground shipping, sea shipping, and air shipping. End users range from pharmaceuticals and biopharmaceutical companies to pharmacies, hospitals, clinics, and other healthcare providers.

North America’s Leading Position in the Bio-Pharmaceutical Logistics Market
North America stands as the largest regional market for bio-pharmaceutical logistics in 2030, valued at $92 billion, up from $61 billion in 2025. This growth, with a CAGR of 9%, reflects increased production of temperature-sensitive biologics and specialty medicines, investments in cold chain infrastructure, and stringent requirements for traceability and quality assurance during transportation. The region’s expanding clinical trial logistics and commercial drug distribution also contribute to its market dominance.

Country-Level Outlook with Focus on the USA
The United States is projected to hold the largest national market share within bio-pharmaceutical logistics in 2030, reaching $82 billion from $55 billion in 2025, growing at an 8% CAGR. Growth is driven by the expansion of domestic biopharmaceutical manufacturing, the rise of digital supply chain monitoring solutions, increased demand for direct-to-patient delivery of specialty therapies, and ongoing investment in validated packaging solutions that safeguard product quality throughout transit.

Competitive Environment in the Global Bio-Pharmaceutical Logistics Market
Global logistics providers and specialized cold chain transportation companies dominate the bio-pharmaceutical logistics space. These players are emphasizing innovations in temperature-controlled transport, real-time monitoring, specialized packaging techniques, and frameworks that comply with regulatory requirements to maintain product safety. Key competitive factors include strict adherence to pharmaceutical regulations, comprehensive supply chain visibility, and reliable service delivery, supported by digital tracking and data management systems.

Market Share Distribution and Concentration Analysis
The market remains relatively fragmented, with the top 10 players controlling about 14% of total revenue in 2025. Moderate technological and regulatory barriers exist due to stringent pharmaceutical transportation standards, cold chain mandates, and specialized handling needs. Leading firms maintain significant shares by offering diverse logistics portfolios, forming strong partnerships with pharmaceutical companies, leveraging global cold chain networks, and continually innovating biopharmaceutical supply chain solutions. Growing demands for temperature-controlled logistics and real-time shipment tracking are expected to drive further strategic collaborations and regional expansions.

Key Market Leaders with Share Details
Among the foremost companies by market share in 2025 are:
- DHL (Dalsey, Hillblom and Lynn) — 2%
- Kuehne + Nagel International AG — 2%
- United Parcel Service Inc. — 2%
- FedEx Corporation — 2%
- DSV A/S (DB Schenker) — 2%
- CEVA Logistics — 1%
- GEODIS S.A. — 1%
- World Courier Inc. — 1%
- AmerisourceBergen Corporation (Cencora, Inc.) — 1%
- Cardinal Health Inc. — 1%

Innovations Shaping the Future of Bio-Pharmaceutical Logistics
The integration of IoT-enabled temperature-controlled packaging is revolutionizing shipment monitoring and product traceability in this market. For example, Cold Chain Technologies LLC introduced its CCT tower elite in April 2025, a reusable, IoT-enabled temperature-controlled pallet shipper designed for pharmaceutical and biotech products. This solution enhances temperature visibility, asset management, and cost efficiency, thereby improving supply chain reliability for sensitive shipments.

Top Growth Opportunities Within Bio-Pharmaceutical Logistics
The cold chain and non-cold chain logistics segments represent the most promising areas for growth. Together, they are expected to contribute over $101 billion in additional market value by 2030, with cold chain logistics accounting for $70 billion and non-cold chain logistics for $31 billion between 2025 and 2030. This growth is underpinned by increased production of biologics and specialty pharmaceuticals, rising demand for temperature-controlled transport of vaccines and cell and gene therapies, expansion of global clinical trials needing secure logistics, and stricter compliance with product integrity, traceability, and GDP requirements.

Strategies Guiding Market Competitiveness
Companies in this space are focusing on several strategic areas to boost their competitiveness, including:
- Developing advanced temperature-controlled logistics technologies that ensure product safety and regulatory compliance
- Utilizing IoT-based monitoring systems to enhance shipment visibility and traceability
- Expanding cold chain infrastructure to improve distribution and supply networks
- Implementing AI-driven analytics to increase operational efficiency and data insights

Major Players Influencing the Bio-Pharmaceutical Logistics Market Landscape
Key organizations shaping this market include DHL (Dalsey, Hillblom and Lynn), Kuehne + Nagel International AG, United Parcel Service Inc., FedEx Corporation, DSV A/S (DB Schenker), CEVA Logistics, GEODIS S.A., World Courier Inc., AmerisourceBergen Corporation (Cencora, Inc.), Cardinal Health Inc., Nippon Express Holdings, C.H. Robinson Worldwide Inc., Agility Public Warehousing Company K.S.C.P., Cryoport Inc., Envirotainer, Csafe Global, Thermo Fisher Scientific Inc., Kerry Logistics Network Limited, Parexel International Corporation, Air Canada Cargo, SF Express Co. Ltd., Biocair International Ltd., Movianto Group Companies, Almac Group, PCI Pharma Services Holdings LLC, PHSE Srl, and Tower Cold Chain.

Supply Chain Dynamics and Customer Base in Bio-Pharmaceutical Logistics
The supply chain encompasses a broad array of stakeholders. Key raw material suppliers include companies like Becton, Dickinson and Company, Thermo Fisher Scientific Inc., Merck KGaA, Sartorius AG, Danaher Corporation, Bio-Rad Laboratories, Agilent Technologies, Lonza Group AG, Catalent, Charles River Laboratories, WuXi AppTec, Samsung Biologics, Fujifilm Diosynth Biotechnologies, Evonik Industries, BASF SE, Corning Incorporated, Avantor, Cytiva, Eppendorf SE, Getinge AB, Integra LifeSciences, Repligen Corporation, Bio-Techne Corporation, Kaneka Corporation, and Asahi Kasei Corporation.

Wholesalers and distributors include DHL Supply Chain, Kuehne + Nagel, DB Schenker, UPS Healthcare, FedEx, World Courier, Marken Ltd., QuickSTAT, Movianto GmbH, Alloga AG, Zuellig Pharma Holdings, PHSE S.p.A., Eurotranspharma, Trans-o-flex ThermoMed GmbH, Nippon Express Holdings, Yusen Logistics, Expeditors International, DSV A/S, CEVA Logistics, Bolloré Logistics, Hellmann Worldwide Logistics, Agility Logistics, GEODIS, Rhenus Logistics, and Kintetsu World Express.

The end user base features major pharmaceutical and biopharmaceutical companies such as Pfizer, Moderna, Johnson & Johnson Innovative Medicine, AstraZeneca, Novartis, Roche, Bristol Myers Squibb, Eli Lilly, AbbVie, Amgen, Gilead Sciences, Sanofi, Takeda Pharmaceutical, Bayer, Novo Nordisk, Vertex Pharmaceuticals, Regeneron, Biogen, CSL Limited, Alexion Pharmaceuticals, Genmab, Alnylam Pharmaceuticals, BioMarin Pharmaceutical, Sarepta Therapeutics, and Jazz Pharmaceuticals.

What’s included in our 2026 market reports:

• Market attractiveness scoring and analysis
• Total addressable market (TAM) analysis
• Company scoring matrix graphics and tables
• Excel-based forecasting dashboards
• Market hotspots infographics
• Key technologies and future trend analysis
• Updated graphics and tables

About The Business Research Company
The Business Research Company (www.thebusinessresearchcompany.com) is a renowned market intelligence firm specializing in company, market, and consumer research. With over 30,000+ reports spanning 27 industries and more than 60 geographies, their insights draw upon 1.5 million datasets, extensive secondary research, and interviews with industry leaders. They offer a range of tailored research packages such as Market Entry, Competitor Tracking, and Supplier & Distributor packages.

Disclaimer: The information provided by TBRC Business Research Pvt Ltd is gathered in good faith from primary and secondary sources, though accuracy cannot be fully guaranteed. The company disclaims liability for any actions taken based on its findings, which are intended as estimates and opinions rather than definitive facts or investment advice.

Contact Information
The Business Research Company
Americas: +1 310-496-7795
Europe: +44 7882 955267
Asia & Others: +44 7882 955267 / +91 8897263534
Email: marketing@tbrc.info

Follow on LinkedIn: https://in.linkedin.com/company/the-business-research-company"

Oliver Guirdham
The Business Research Company
+ +44 7882 955267
info@tbrc.info
Visit us on social media:
LinkedIn
Facebook
X